Page 3 - Timothyp Walbert News Today

Congress Asset Management Co. MA decreased its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 2.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,615,559 shares of the biopharmaceutical company’s stock after selling 46,547 […]

Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) have been assigned a consensus recommendation of “Buy” from the ten brokerages that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the […]

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) has been given a consensus rating of “Buy” by the ten research firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have given a buy recommendation to the […]

Liontrust Investment Partners LLP reduced its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 22.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 185,242 shares of the biopharmaceutical company’s stock after selling 55,000 shares during the period. Liontrust Investment Partners […]

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) saw some unusual options trading activity on Friday. Stock investors purchased 8,739 call options on the company. This is an increase of 580% compared to the typical volume of 1,285 call options. Shares of NASDAQ:HZNP traded down $0.56 during midday trading on Friday, hitting $109.25. 9,303 shares […]

Equities research analysts expect that Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) will post sales of $868.41 million for the current quarter, Zacks reports. Four analysts have provided estimates for Horizon Therapeutics Public’s earnings, with the highest sales estimate coming in at $883.55 million and the lowest estimate coming in at $846.97 million. Horizon […]

Oppenheimer began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a report issued on Monday morning, The Fly reports. The brokerage issued an outperform rating on the biopharmaceutical company’s stock. HZNP has been the subject of a number of other research reports. Piper Sandler reduced their price objective on shares of […]

Analysts forecast that Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) will report $1.16 earnings per share for the current quarter, Zacks reports. Four analysts have made estimates for Horizon Therapeutics Public’s earnings, with the highest EPS estimate coming in at $1.27 and the lowest estimate coming in at $1.10. Horizon Therapeutics Public reported earnings […]

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

Following revelations about falsified data, a host of executives and board members, including the co-founder and Horizon Therapeutics' CEO, have left the biotech startup as it works to stop a "cash burn."